Clinical Trial Update: Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell Lymphoma [NA]

View source ↗

Summary

This clinical trial evaluates whether liver SUVmax from 18F-FDG PET/CT can predict prognosis in patients with Diffuse large B-cell lymphoma. The sponsor is Peki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Lymphoma, Large B-Cell, Diffuse | NA | Status: UNKNOWN